BCV vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
BCV exhibits a stable financial profile with a Piotroski F-Score of 6/9 and an exceptionally strong value proposition. The stock is trading at a massive discount to its Graham Number ($64.45) and Intrinsic Value ($217.41), supported by an incredibly low P/E ratio of 3.24 and a Price/Book of 0.95. While technical trends are currently bearish and revenue growth is slightly negative, the explosive earnings growth (432.40% YoY) and high ROE (27.25%) suggest a highly efficient operation. The dividend is well-covered with a low payout ratio of 17.37%, making this a compelling deep-value play.
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
Compare Another Pair
Related Comparisons
BCV vs JPM: Head-to-Head Comparison
This page compares Bancroft Fund Ltd. (BCV) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.